Literature DB >> 16364335

Enantioseparation of 2-aryloxypropionic acids on chiral porous monolithic columns by capillary electrochromatography. Evaluation of column performance and enantioselectivity.

Antonella Messina1, Miroslav Flieger, Fiorella Bachechi, Massimo Sinibaldi.   

Abstract

The enantioseparation of 2-aryloxypropionic acids by capillary electrochromatography was tested on columns with a monolithic stationary phase prepared from silanized fused-silica capillaries (100 microm I.D.) by in situ copolymerization of glycidyl methacrylate, ethylene glycol dimethacrylate and methyl methacrylate in the presence of formamide and 1-propanol as the porogen solvents. The porous chiral monolithic stationary phases were prepared by reaction of the epoxy-groups at the surface of the monolith with (+)-1-(4-aminobutyl)-(5R,8S,10R)-terguride. To attain the minimum HETP values for the enantiodiscrimination of 2-phenoxypropionic acid, the influence of the composition of polymerization solution on column total porosity and efficiency was investigated. Optimum mobile phase conditions were found for all analytes tested using acetonitrile-methanol mixtures containing triethylamine and acetic acid as the buffer components. Furthermore, the chemical and mechanical stabilities of the columns were satisfactory, allowing hundreds of analyses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16364335     DOI: 10.1016/j.chroma.2005.11.107

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  2 in total

Review 1.  CEC: selected developments that caught my eye since the year 2000.

Authors:  Frantisek Svec
Journal:  Electrophoresis       Date:  2009-06       Impact factor: 3.535

2.  A novel positively charged achiral co-monomer for β-cyclodextrin monolithic stationary phase: improved chiral separation of acidic compounds using capillary electrochromatography coupled to mass spectrometry.

Authors:  William Bragg; Shahab A Shamsi
Journal:  J Chromatogr A       Date:  2012-08-19       Impact factor: 4.759

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.